Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels

被引：17
|
作者：
Gazeau, Pierre [1 ,2 ]
Devauchelle-Pensec, Valerie [1 ,2 ]
Pochard, Pierre [2 ]
Pers, Jacques-Olivier [2 ]
Saraux, Alain [1 ,2 ]
Renaudineau, Yves [2 ,3 ]
Cornec, Divi [1 ,2 ]
机构：
[1] CHRU Brest, Serv Rhumatol, Brest, France
[2] Univ Brest, INSERM ESPRI, ERI29, EA 2216,LabEx IGO, Brest, France
[3] CHRU Brest, Lab Immunol, Brest, France
来源：
RHEUMATOLOGY | 2016年 / 55卷 / 06期
关键词：
ACTIVATION;
D O I：
10.1093/rheumatology/kev417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1138 / 1140
页数：3
相关论文
共 50 条
  • [41] Dominant B-Cell Receptor Clones in Peripheral Blood Predict Onset of Arthritis in Individuals at Risk for Rheumatoid Arthritis
    Tak, Paul-Peter
    Doorenspleet, Marieke E.
    de Hair, Maria
    Klarenbeek, Paul L.
    van Beers-Tas, Marian
    van Kampen, Antoine H. C.
    van Schaardenburg, Dirkjan
    Gerlag, Danielle M.
    Baas, Frank
    de Vries, Niek
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1119 - 1128
  • [43] DOMINANT B-CELL RECEPTOR CLONES IN PERIPHERAL BLOOD PREDICT ONSET OF ARTHRITIS IN INDIVIDUALS AT RISK FOR RHEUMATOID ARTHRITIS
    Tak, Paul-Peter
    Doorenspleet, Marieke E.
    de Hair, Marjolein J. H.
    Klarenbeek, Paul L.
    van Beers-Tas, Marjan H.
    van Kampen, Antoine H. C.
    van Schaardenburg, Dirkjan
    Gerlag, Danielle M.
    Baas, Frank
    de Vries, Niek
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A83 - A84
  • [44] DOMINANT B-CELL RECEPTOR CLONES IN PERIPHERAL BLOOD PREDICT ONSET OF ARTHRITIS IN INDIVIDUALS AT RISK FOR RHEUMATOID ARTHRITIS
    Tak, P. -P.
    Doorenspleet, M. E.
    de Hair, M.
    Klarenbeek, P.
    van Beers-Tas, M.
    van Kampen, A.
    van Schaardenburg, D.
    Gerlag, D.
    Baas, F.
    de Vries, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 124 - 124
  • [45] Evaluation of B cell related markers and autoantibodies in rheumatoid arthritis patients treated with abatacept
    Wang, Ting
    Giltiay, Natalia V.
    Lood, Christian
    Wang, Ning
    Han, Bobby Kwanghoon
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [46] B cells, be gone - B-cell depletion in the treatment of rheumatoid arthritis
    Tsokos, GC
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25): : 2546 - 2548
  • [47] Abatacept Reduces Levels of Switched Memory B Cells, Autoantibodies, and Immunoglobulins in Patients with Rheumatoid Arthritis
    Scarsi, Mirko
    Paolini, Lucia
    Ricotta, Doris
    Pedrini, Antonio
    Piantoni, Silvia
    Caimi, Luigi
    Tincani, Angela
    Airo, Paolo
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 666 - 672
  • [48] Baseline T Cell and B Cell-related Markers and HLA-DRB1 Shared Epitope Alleles Predict the Therapeutic Efficacy of Abatacept in Patients with Moderate to Severe Rheumatoid Arthritis
    Wang, Ting
    Giltiay, Natalia V.
    Lood, Christian
    Han, Bobby Kwanghoon
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 854 - 856
  • [49] EVIDENCE FOR OLIGOCLONAL B-CELL EXPANSION IN THE PERIPHERAL-BLOOD OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    FOX, DA
    SMITH, BR
    ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (12) : 991 - 995
  • [50] REDUCED B-CELL GALACTOSYLTRANSFERASE ACTIVITY IN RHEUMATOID-ARTHRITIS
    AXFORD, JS
    LYDYARD, PM
    ISENBERG, DA
    MACKENZIE, L
    HAY, FC
    ROITT, IM
    LANCET, 1987, 2 (8574): : 1486 - 1488
12345